CONTEXT: Building on established methods for CT virtual colonoscopy, Dr. Jamey Weichert, an associate professor of radiology at the University of Wisconsin, Madison, and colleagues tested a method for colonic tumor detection and characterization using PET/CT imaging.
CONTEXT: Building on established methods for CT virtual colonoscopy, Dr. Jamey Weichert, an associate professor of radiology at the University of Wisconsin, Madison, and colleagues tested a method for colonic tumor detection and characterization using PET/CT imaging. Iodine-124 NM404 (a radioiodinated phospholipid ether analog) was used as a PET tracer. NM404 has shown prominent tumor avidity and prolonged tumor retention in more than 30 preclinical malignant tumor types and in early clinical evaluation of lung cancer patients. Fluorine-18 FDG-PET was used for comparison. When labeled with iodine-125 or other radioisotopes commonly used in radiotherapy, NM404 has also shown promise as a radioimmunotherapeutic agent.
RESULTS: Two PIRC rats (a transgenic model for testing colon cancer progression) were injected with F-18 FDG followed 24 hours later by an injection of 124I-NM404. MicroPET and microCT scans were performed immediately following FDG injection and at 24 and 96 hours after NM404 injection. The in vivo NM404 microPET/microCT data distinguished three lesions as adenocarcinomas. Results confirmed a high degree of specificity for malignancy with NM404, while FDG did not differentiate between malignant and benign lesions.
IMAGE: In vivo microCT virtual colonoscopy fly-through of a PIRC rat indicates NM404 uptake in three potentially cancerous lesions.
IMPLICATIONS: The study is part of a larger program to establish clinical trials for NM404 dual-modality virtual colonoscopy. Future research will calculate standardized uptake values of NM404 versus FDG in colonic lesions in greater numbers of mice.
FDA Clears AI-Powered Quantitative Perfusion Mapping for Cone-Beam CT
May 6th 2024Reportedly validated in more than 10 clinical trials, the AngioFlow perfusion imaging software enables timely identification of brain regions with cerebral blood flow reduction and those with significant hypoperfusion.
Can a CT-Based Radiomics Model Bolster Detection of Malignant Thyroid Nodules?
May 3rd 2024A computed tomography (CT)-based radiomics model that includes 28 radiomic features showed significantly higher accuracy, sensitivity, and specificity than conventional CT in differentiating benign and malignant thyroid nodules, according to newly published research.
Breast MRI and Dense Breasts: A Closer Look at Early Findings from a New Prospective Trial
May 2nd 2024Supplemental breast MRI had a cancer detection rate (CDR) of 20/1000 and a positive predictive value (PPV) of 50 percent, according to preliminary findings from a prospective trial involving women with heterogeneously or very dense breasts.